J&J reports double-digit drop in OTC sales

23 April 2021 - Deborah Wilkes

Premium

Johnson & Johnson (J&J) reported a double-digit drop in its OTC sales during the first quarter of 2021, as the COVID-19 pandemic took its toll in multiple ways.

Click tags below for more information on topics:

Johnson & Johnson COVID-19

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: